SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Zuellig Pharma Acquires Newly Licensed Hangzhou Facility

The acquisition establishes local sourcing capabilities in China, according to the company.

Related stories